A Bivalent Conjugate Vaccine in the Treatment of Biochemically Relapsed Prostate Cancer: A Study of Glycosylated Muc-2-Klh and Globo H-Klh Conjugate Vaccines Given with the New Semi-Synthetic Saponin Immunological Adjuvant Gpi-0100 or Qs-21
AuthID
P-008-NPC
P-008-NPC